RNXT
RenovoRx, Inc. Common Stock
stockNASDAQ
renovorx is a medical device company headquartered in silicon valley, california. we are developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. the ability to deliver these materials at high concentration to specific vasculature, safely and without perfusion overlap to other regions, is a central paradigm of our technology. we have received fda clearance for the renovocath™ rc120 and are now introducing our innovative technology to the clinical market. renovorx is a highly motivated team with broad experience and an exciting vision for the future of targeted delivery. we are backed by a broad medical advisory board and a strong board of directors. please contact us at info@renovorx.com to learn more.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.55 | 2026-09-28 | +2.26% | 1.629 |
| 1M | 2.39 | 2026-09-04 | -33.68% | 5.040 |
| 3M | 0.95 | 2026-07-06 | +67.27% | 2.480 |
| 6M | 0.93 | 2026-04-06 | +70.08% | 1.932 |
| 1Y | 1.34 | 2025-10-06 | +18.28% | 1.490 |
| 2Y | 1.02 | 2024-10-04 | +55.39% | — |
| 5Y | 5.72 | 2021-10-05 | -72.29% | 0.884 |
RenovoRx, Inc. Common Stock (NASDAQ:RNXT) stock price today is $1.59, and today's volume is 269,371. RNXT is up 2.258% today. The 30 day average volume is 1.18M. RNXT market cap is $71.53M with 45.13M shares outstanding.